To further assess the ability of WL-12@Fe3O4 nanoprobes to detect PD-L1 expression in tumors in vivo, MRI was used to dynamically monitor the uptake of nontargeted and targeted nanoprobes in tumor tissues. This evidence concerns the gene CD274 and neoplasm.